Logo image of RARX

Ra Pharmaceuticals Inc (RARX) Stock Analyst Ratings

USA - NASDAQ:RARX -

47.995
-0.02 (-0.03%)
Last: 4/1/2020, 8:11:30 PM
47.995
0 (0%)
After Hours: 4/1/2020, 8:11:30 PM
Buy % Consensus

60

ChartMill assigns a Buy % Consensus number of 60% to RARX. The Buy consensus is the weighted average rating of the current analysts ratings.

RARX was analyzed by 7 analysts. The buy percentage consensus is at 60. So analysts seem to be rather neutral about RARX.
In the previous month the buy percentage consensus was at a similar level.
RARX was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

RARX Historical Analyst RatingsRARX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -15 -14 -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6

Related screens

RARX Current Analyst RatingRARX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Ra Pharmaceuticals Inc / RARX FAQ

What is the consensus rating for Ra Pharmaceuticals Inc (RARX) stock?

The consensus rating for Ra Pharmaceuticals Inc (RARX) is 60 / 100 . This indicates that analysts generally have a neutral outlook on the stock.


How many analysts have analysed Ra Pharmaceuticals Inc (RARX)?

The number of analysts covering Ra Pharmaceuticals Inc (RARX) is 7.